Home Cart Sign in  
Chemical Structure| 2170695-14-2 Chemical Structure| 2170695-14-2

Structure of dTRIM24
CAS No.: 2170695-14-2

Chemical Structure| 2170695-14-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

dTRIM24 is a potent and selective PROTAC targeting on TRIM24 which has been posited as a dependency in numerous cancers, with TRIM24 ligand IACS-9571 conjugated to a VHL ligand.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of dTRIM24

CAS No. :2170695-14-2
Formula : C55H68N8O13S2
M.W : 1113.30
SMILES Code : CC1=C(C2=CC=C(CNC([C@@H]3C[C@@H](O)CN3C([C@H](C(C)(C)C)NC(COCCOCCOCCNC(C4=CC=CC(S(=O)(NC5=CC(N(C)C(N6C)=O)=C6C=C5OC7=CC(OCCC)=CC=C7)=O)=C4)=O)=O)=O)=O)C=C2)SC=N1
MDL No. :MFCD31692370

Safety of dTRIM24

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of dTRIM24

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
JBR 2.5, 5, 7.5, 10, 12.5 µM 24 hours To evaluate the effect of dTRIM24 on TRIM24 and p53 levels, results showed dTRIM24 dose-dependently reduced TRIM24 levels. Cell Death Discov. 2025 Mar 17;11(1):108
JeKo-1 2.5, 5, 7.5, 10, 12.5 µM 24 hours To evaluate the effect of dTRIM24 on TRIM24 and p53 levels, results showed dTRIM24 dose-dependently reduced TRIM24 levels. Cell Death Discov. 2025 Mar 17;11(1):108
ZBR 2.5, 5, 10 µM 24 hours To evaluate the effect of dTRIM24 on TRIM24 and p53 levels, results showed dTRIM24 dose-dependently reduced TRIM24 levels and increased p53 accumulation. Cell Death Discov. 2025 Mar 17;11(1):108
Z-138 2.5, 5, 10 µM 24 hours To evaluate the effect of dTRIM24 on TRIM24 and p53 levels, results showed dTRIM24 dose-dependently reduced TRIM24 levels and increased p53 accumulation. Cell Death Discov. 2025 Mar 17;11(1):108
GBM#BG5 cells 5, 10 μM inhibited cell proliferation J Transl Med. 2021 Dec 9;19(1):505
GBM#06 cells 5, 10 μM inhibited cell proliferation J Transl Med. 2021 Dec 9;19(1):505
GBM#BG7 cells 5, 10 μM inhibited cell proliferation J Transl Med. 2021 Dec 9;19(1):505
Raw 264.7 cells (M1 macrophages) 0.31, 0.62, 1.25, 2.50, 5.00 μg/mL 24 hours Evaluate the effect of MELT on M1 macrophage polarization to M2 phenotype. Results showed MELT significantly downregulated iNOS (M1 marker) and upregulated Arg1 (M2 marker), promoting M2 polarization. Acta Pharmacol Sin. 2023 Oct;44(10):1962-1976
MOLM-13 cells 2.5 µM 24 hours Evaluate the degradation effect of dTRIM24 on TRIM24 protein, showing time-dependent degradation Nat Chem Biol. 2018 Apr;14(4):405-412
293FT cells 5 µM 24 hours Evaluate the degradation effect of dTRIM24 on TRIM24 protein, showing dose-dependent degradation Nat Chem Biol. 2018 Apr;14(4):405-412
GBM#P3 cells 5, 10 μM 48 hours inhibited tumorsphere formation and expression of stemness markers SOX2 and Nestin J Transl Med. 2021 Dec 9;19(1):505

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Chicken embryo Chick embryo chorioallantoic membrane (CAM) model Topical administration 5 nM BTZ, 10 µM dTRIM24 Twice weekly until embryonic day 16 To evaluate the effect of dTRIM24 and BTZ combination therapy on tumor growth and metastasis, results showed the combination significantly inhibited tumor growth and metastasis. Cell Death Discov. 2025 Mar 17;11(1):108
ApoE−/− mice Atherosclerosis model Intravenous injection 5 mg/kg Every 3 days for 31 days Evaluate the anti-atherosclerotic effects of MELT in vivo. Results showed MELT significantly reduced aortic plaque area (over 60% reduction) and promoted M2 macrophage polarization. Acta Pharmacol Sin. 2023 Oct;44(10):1962-1976

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.90mL

0.18mL

0.09mL

4.49mL

0.90mL

0.45mL

8.98mL

1.80mL

0.90mL

References

 

Historical Records

Categories